Search Results - "Rusev, B."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis by Chattaragada, M S, Riganti, C, Sassoe, M, Principe, M, Santamorena, M M, Roux, C, Curcio, C, Evangelista, A, Allavena, P, Salvia, R, Rusev, B, Scarpa, A, Cappello, P, Novelli, F

    Published in Oncogene (08-02-2018)
    “…Mitochondrial dysregulation plays a central role in cancers and drives reactive oxygen species (ROS)-dependent tumor progression. We investigated the…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids by Nicosia, L., Andreani, S., Ruggieri, R., Rusev, B., Lawlor, R.T., Pea, A., Agolli, L., Scarpa, A., Corbo, V., D'Agosto, S., Alongi, F.

    “…Pancreatic ductal adenocarcinoma (PDAC) is highly refractory to systemic treatment, including radiotherapy (RT) either as alone or in combination with…”
    Get full text
    Journal Article
  8. 8
  9. 9

    1405PValidation of a tumour mutational burden workflow on routine histological samples of colorectal cancer and assessment of a cohort with synchronous hepatic metastases by Mafficini, A, Cantù, C, Antonello, D, Simbolo, M, Piredda, L, Lever, V, Rusev, B, Pecori, S, Milella, M, Lawlor, R T, Scarpa, A

    Published in Annals of oncology (01-10-2019)
    “…Abstract Background Colorectal carcinoma 5-year survival ranges from 90% in patients with localized disease to 15% for those with distant metastasis. Recent…”
    Get full text
    Journal Article
  10. 10

    1405P - Validation of a tumour mutational burden workflow on routine histological samples of colorectal cancer and assessment of a cohort with synchronous hepatic metastases by Mafficini, A., Cantù, C., Antonello, D., Simbolo, M., Piredda, L., Lever, V., Rusev, B., Pecori, S., Milella, M., Lawlor, R.T., Scarpa, A.

    Published in Annals of oncology (01-10-2019)
    “…Colorectal carcinoma 5-year survival ranges from 90% in patients with localized disease to 15% for those with distant metastasis. Recent research has suggested…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13